SLC44A2 and colorectal carcinoma: In this study, we observed a marked reduction in SLC44A2 expression in colorectal cancer (CRC) and found that low SLC44A2 expression was significantly correlated with increased tumor size, higher incidence of tumor thrombus, and poorer survival in CRC patients.